Human medicines European public assessment report (EPAR): Denbrayce, denosumab, Date of authorisation: 26/06/2025, Revision: 2, Status: Authorised
Agenda of the CAT meeting 11-13 May 2026
Applications for new human medicines under evaluation: May 2026
Herbal medicinal product: Hamamelidis cortex, Hamamelis virginiana L., F: Assessment finalised
Herbal medicinal product: Hamamelidis folium, Hamamelis virginiana L., F: Assessment finalised
Herbal medicinal product: Hamamelidis folium et cortex aut ramunculus destillatum, Hamamelis virginiana L., F: Assessment finalised
Antimicrobial Sales and Use (ASU) Platform: Release notes
Olazax : EPAR - Procedural steps taken and scientific information after authorisation (archive)
Agenda - EnprEMA & ACT EU workshop on paediatric clinical trials
Human medicines European public assessment report (EPAR): Ojemda, tovorafenib, Date of authorisation: 20/04/2026, Status: Authorised